The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B
The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B
Human soluble CD52 is a short glycopeptide comprising 12 amino acids (GQNDTSQTSSPS) which functions as an immune regulator by sequestering the pro-inflammatory high mobility group box protein 1 (HMGB1) and suppressing immune responses. Recombinant CD52 has been shown to act as a broad anti-inflammatory agent, dampening both adaptive and innate immune responses. This short glycopeptide is heavily glycosylated, with a complex sialylated N-linked glycan at N3 and reported O-linked glycosylation possible on several serine and threonine residues. Previously we demonstrated that specific glycosylation features of CD52 are essential for its immunosuppressive function, with terminal α-2,3-linked sialic acids required for binding to the inhibitory SIGLEC-10 receptor leading to T-cell suppression. Using high resolution mass spectrometry, we have further characterized the N- and O-linked glycosylation of Expi293 recombinantly produced CD52 at a glycopeptide and released glycan level, accurately determining glycan heterogeneity of both N- and O-linked glycosylation, and localizing the site of O-glycosylation to T8 with high confidence and direct spectral evidence. This detailed knowledge of CD52 glycosylation informed the construction of a model system, which we analyzed by molecular dynamics simulations to understand the mechanism of recognition and define interactions between bioactive CD52, HMGB1 and the SIGLEC-10 receptor. Our results confirm the essential role of glycosylation, more specifically hyper-sialylation, in the function of CD52, and identify at the atomistic level specific interactions between CD52 glycans and the Box B domain of HMGB1 that determine recognition, and the stability of the CD52/HMGB1 complex. These insights will inform the development of synthetic CD52 as an immunotherapeutic agent.
CD52, glycomics, glycoprotein, HMGB1, mass spectrometry, molecular dynamics
DeBono, Nicholas J.
425ceaf9-ef4a-40ae-a7c9-21b34511276a
D'Andrea, Silvia
05bebc27-32c5-4195-8117-e909181af2f4
Bandala-Sanchez, Esther
525e49c4-936e-4136-bf84-8f8247947fcf
Goddard-Borger, Ethan
4a77934b-a3b4-439b-b213-f6380ca435d1
Zenaidee, Muhammad A.
81f377c7-4dda-4f2c-a39e-5d05be10e824
Moh, Edward S.X.
3f0cf876-8863-44be-bcfe-d485d5341861
Fadda, Elisa
11ba1755-9585-44aa-a38e-a8bcfd766abb
Harrison, Leonard C.
0ec7440f-4a73-48b7-b024-93f44c62a558
Packer, Nicolle H.
ad55bbf3-4fa2-407f-a2e3-6392af253ce2
1 April 2025
DeBono, Nicholas J.
425ceaf9-ef4a-40ae-a7c9-21b34511276a
D'Andrea, Silvia
05bebc27-32c5-4195-8117-e909181af2f4
Bandala-Sanchez, Esther
525e49c4-936e-4136-bf84-8f8247947fcf
Goddard-Borger, Ethan
4a77934b-a3b4-439b-b213-f6380ca435d1
Zenaidee, Muhammad A.
81f377c7-4dda-4f2c-a39e-5d05be10e824
Moh, Edward S.X.
3f0cf876-8863-44be-bcfe-d485d5341861
Fadda, Elisa
11ba1755-9585-44aa-a38e-a8bcfd766abb
Harrison, Leonard C.
0ec7440f-4a73-48b7-b024-93f44c62a558
Packer, Nicolle H.
ad55bbf3-4fa2-407f-a2e3-6392af253ce2
DeBono, Nicholas J., D'Andrea, Silvia, Bandala-Sanchez, Esther, Goddard-Borger, Ethan, Zenaidee, Muhammad A., Moh, Edward S.X., Fadda, Elisa, Harrison, Leonard C. and Packer, Nicolle H.
(2025)
The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B.
Journal of Biological Chemistry, 301 (4), [108350].
(doi:10.1016/j.jbc.2025.108350).
Abstract
Human soluble CD52 is a short glycopeptide comprising 12 amino acids (GQNDTSQTSSPS) which functions as an immune regulator by sequestering the pro-inflammatory high mobility group box protein 1 (HMGB1) and suppressing immune responses. Recombinant CD52 has been shown to act as a broad anti-inflammatory agent, dampening both adaptive and innate immune responses. This short glycopeptide is heavily glycosylated, with a complex sialylated N-linked glycan at N3 and reported O-linked glycosylation possible on several serine and threonine residues. Previously we demonstrated that specific glycosylation features of CD52 are essential for its immunosuppressive function, with terminal α-2,3-linked sialic acids required for binding to the inhibitory SIGLEC-10 receptor leading to T-cell suppression. Using high resolution mass spectrometry, we have further characterized the N- and O-linked glycosylation of Expi293 recombinantly produced CD52 at a glycopeptide and released glycan level, accurately determining glycan heterogeneity of both N- and O-linked glycosylation, and localizing the site of O-glycosylation to T8 with high confidence and direct spectral evidence. This detailed knowledge of CD52 glycosylation informed the construction of a model system, which we analyzed by molecular dynamics simulations to understand the mechanism of recognition and define interactions between bioactive CD52, HMGB1 and the SIGLEC-10 receptor. Our results confirm the essential role of glycosylation, more specifically hyper-sialylation, in the function of CD52, and identify at the atomistic level specific interactions between CD52 glycans and the Box B domain of HMGB1 that determine recognition, and the stability of the CD52/HMGB1 complex. These insights will inform the development of synthetic CD52 as an immunotherapeutic agent.
Text
PIIS0021925825001991
- Version of Record
More information
e-pub ahead of print date: 25 February 2025
Published date: 1 April 2025
Additional Information:
Publisher Copyright:
© 2025 The Authors
Keywords:
CD52, glycomics, glycoprotein, HMGB1, mass spectrometry, molecular dynamics
Identifiers
Local EPrints ID: 501843
URI: http://eprints.soton.ac.uk/id/eprint/501843
ISSN: 0021-9258
PURE UUID: c0dbe5a6-4a28-4925-a8ce-65b31b1a0b69
Catalogue record
Date deposited: 10 Jun 2025 18:32
Last modified: 22 Aug 2025 02:42
Export record
Altmetrics
Contributors
Author:
Nicholas J. DeBono
Author:
Silvia D'Andrea
Author:
Esther Bandala-Sanchez
Author:
Ethan Goddard-Borger
Author:
Muhammad A. Zenaidee
Author:
Edward S.X. Moh
Author:
Elisa Fadda
Author:
Leonard C. Harrison
Author:
Nicolle H. Packer
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics